Navigating the procurement of authentic recombinant follistatin requires rigorous verification of molecular identity, isoform specificity, and batch purity. PX1 Research provides verified, high-purity follistatin reagents exclusively for in vitro experimentation and animal model research.
Navigating the procurement of authentic recombinant follistatin requires rigorous verification of molecular identity, isoform specificity, and batch purity. PX1 Research provides verified, high-purity follistatin reagents exclusively for in vitro experimentation and animal model research.
To buy original follistatin for laboratory research, principal investigators must demand lot-specific third-party analytical documentation, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity and Mass Spectrometry (MS) for sequence validation. Authentic follistatin reagents supplied by PX1 Research are synthesized in USA-based, GMP-compliant facilities, ensuring high-purity biological activity, verified molecular mass, and strict endotoxin compliance for cell culture and preclinical assays.
When purchasing recombinant proteins, acquiring genuine material is critical to preventing experimental artifacting caused by truncated peptide sequences, misfolded tertiary structures, or bacterial lipopolysaccharide (LPS) contamination. Researchers can access our fully documented authentic research-grade follistatin alongside our complete comprehensive peptide catalog for institutional research application.
Follistatin (FST) is an autocrine, single-chain monomeric glycoprotein expressed in virtually all vascularized tissues. Biochemically, the peptide contains three domain modules (FSD1, FSD2, and FSD3) rich in cysteine residues, facilitating complex disulfide bonding critical to its binding affinity for ligands within the Transforming Growth Factor-Beta (TGF-β) superfamily.
In nature, differential splicing of the primary mRNA transcript yields two core primary translation products: Follistatin-315 (FS-315) and Follistatin-288 (FS-288). A third widely referenced variant, Follistatin-344 (FS-344), represents a precursor protein containing a 29-amino-acid signal peptide that is naturally cleaved to form the circulating FS-315 isoform. In preclinical research setups, recombinant FS-344 and FS-288 are deployed to study localized versus systemic ligand neutralization.
FS-288 exhibits high affinity for cell-surface heparin sulfate proteoglycans due to an exposed basic amino acid sequence, making it ideal for localized cell-culture studies. Conversely, FS-315 contains an acidic C-terminal extension that masks the heparin-binding domain, allowing it to circulate systemically in preclinical animal models. Selecting the correct isoform is essential when designing protocols targeting localized tissue remodeling or systemic signal inhibition.
The primary mechanism of follistatin centers on its potent, high-affinity binding to specific members of the TGF-β superfamily, most notably Myostatin (Growth Differentiation Factor 8 / GDF-8), Activin A, Activin B, and Growth Differentiation Factor 11 (GDF-11). Follistatin functions as a competitive antagonist, binding these signaling proteins in solution and preventing them from docking to Activin Type II receptors (ActRIIA and ActRIIB).
By occupying the receptor-binding epitopes of GDF-8 and Activin A, follistatin prevents the recruitment and phosphorylation of Activin Type I receptors (ALK4/ALK5). This blockade arrests downstream intracellular signaling via the Smad2/Smad3 transcription factor pathway. In cellular models of muscle tissue, inhibition of Smad2/Smad3 prevents the transcriptional activation of ubiquitin-proteasome system genes (such as Atrogin-1 and MuRF1), which otherwise drive protein degradation.
Concurrently, the attenuation of Smad signaling releases inhibitory pressure on the Akt/mTOR (mammalian target of rapamycin) cascade. In vitro assays demonstrate that treating myotube cultures with recombinant follistatin increases protein synthesis rates and accelerates myoblast fusion, offering a clear model for investigating hyperplastic and hypertrophic cellular pathways.
Preclinical investigation into follistatin spans several decades, focusing primarily on neuromuscular regeneration, metabolic homeostasis, and fibrotic tissue attenuation. In rodent models of muscular dystrophy and age-related sarcopenia, vector-mediated or recombinant administration of follistatin has yielded significant increases in wet muscle mass, myofiber cross-sectional area, and tetanic force production.
Beyond skeletal muscle, follistatin plays a critical role in reproductive physiology, renal pathology, and hepatic tissue repair models. In vitro co-culture assays demonstrate that follistatin modulates Activin A-mediated inflammatory signals, attenuating collagen deposition and myofibroblast differentiation in models of pulmonary and hepatic fibrosis.
In metabolic research, animal models exposed to follistatin exhibit altered adipose tissue distribution. By modulating the local signaling of TGF-β family ligands within white adipose tissue (WAT), research indicates potential shifts toward brown-like adipose phenotype recruitment (browning), altering systemic energy expenditure and glucose tolerance parameters under hypercaloric feeding conditions.
When evaluating agents within the growth factor signaling axis, investigators frequently compare follistatin with direct receptor blockers, alternative myostatin inhibitors, and endocrine growth factors. Understanding structural and operational differences assists in selecting the precise reagent for specific laboratory endpoints.
While follistatin functions by directly binding and sequestering free ligands (GDF-8, Activins) in the extracellular space, monoclonal antibodies against ActRIIB target the cell-surface receptor itself. Conversely, direct growth factor peptides target distinct tyrosine kinase receptor networks. To illustrate these operational distinctions, consider the comparative profile below:
In comparative preclinical models, researchers exploring myostatin inhibition mechanisms frequently evaluate recombinant follistatin alongside ligands like IGF-1 LR3 and GDF-8 pathway antagonists. While IGF-1 variants drive signaling upstream through the Receptor Tyrosine Kinase (RTK) / Pi3K / Akt axis, follistatin acts downstream on the Smad repressor cascade, providing a complementary approach when studying synergistic hyperplastic pathways in muscle cell lines.
Because recombinant proteins like follistatin require complex expression vectors (typically E. coli or mammalian CHO systems) followed by multi-step refolding protocols, quality verification is significantly more rigorous than that for simple linear synthetic peptides. Unscrupulous suppliers frequently distribute misfolded proteins, incorrect truncated sequences, or severely degraded lyophilized powders.
At PX1 Research, every single lot of follistatin undergoes comprehensive analytical validation in our ISO 17025 accredited testing facilities:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures total purity exceeds 98.0%. Chromatograms confirm the absence of truncated sequences, expression vectors, or degradation products.
2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight against theoretical sequence prediction, confirming correct amino acid length and primary structure.
3. Bacterial Endotoxin Quantitation (LAL Assay): Endotoxin limits are strictly maintained below 0.1 EU/mg using Chromogenic Limulus Amebocyte Lysate testing. Low endotoxin levels are vital to prevent toll-like receptor 4 (TLR4) activation in delicate cell cultures or animal models.
4. SDS-PAGE Gel Electrophoresis: Assesses tertiary monomeric state and confirms the absence of high-molecular-weight aggregates or non-specific protein contaminants.
Investigators can review detailed batch data by visiting our public analytical verification hub, ensuring complete reproducibility before initiating experimental trials.
The supply market for research proteins contains numerous non-verified entities selling unrefined, degraded, or mislabeled materials. Obtaining authentic follistatin requires avoiding common marketplace red flags that indicate compromised reagent integrity.
Common red flags include vendors who do not provide lot-specific Certificates of Analysis (COAs), suppliers displaying static or template COAs lacking batch numbers, and products sold without mass-spectrometry sequence verification. Additionally, proteins offered without quantitative endotoxin metrics present severe risks of cellular toxicity or non-specific inflammatory signaling in research setups.
PX1 Research mitigates these risks by maintaining full lot traceability from synthesis through final packaging. Every vial features a scannable lot code linking directly to verified third-party laboratory data, ensuring that investigators receive authentic, bioactive follistatin every time.
Recombinant proteins are delicate secondary and tertiary macromolecular structures vulnerable to physical shear forces, temperature fluctuations, and pH extremes. Proper handling protocols are mandatory to preserve bioactivity upon receipt.
Upon arrival, lyophilized follistatin should be stored in a manual-defrost freezer at -20°C to -80°C. Prior to reconstitution, vials should be briefly centrifuged to collapse any loose lyophilized cake to the bottom of the container.
Reconstitution should be conducted using sterile, laboratory-grade Bacteriostatic Water or Sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on assay parameters. Avoid aggressive vortexing or rapid pipette dispensing, which introduces air bubbles and promotes protein denaturation; instead, gently swirl the solution until fully dissolved. Reconstituted aliquots should be stored at 4°C for short-term experimentation (under 7 days) or quick-frozen in single-use working aliquots at -80°C to prevent freeze-thaw degradation cycles. For detailed reconstitution calculations, researchers can consult our recombinant peptide handling guide.
PX1 Research serves as a premier USA supplier of pure research compounds, supporting academic institutions, private biotechnology laboratories, and contract research organizations (CROs) globally. We prioritize scientific rigor over commercial hyperbole, adhering strictly to institutional standards.
All products are synthesized under domestic USA manufacturing frameworks adhering to strict Quality Management Systems (QMS). Orders dispatch directly from our climate-controlled fulfillment centers located in California and Arizona. Orders placed Monday through Friday prior to 12:00 PM PST feature same-day dispatch, ensuring cold-chain integrity and rapid delivery to your facility.
For large-scale animal studies, high-throughput screening, or continuous trial runs, laboratories can establish institutional accounts through our dedicated institutional procurement channels to lock in batch-consistent lots for long-term experimental consistency.
How can I verify if my Follistatin reagent is authentic?
Authenticity is verified via lot-specific Certificates of Analysis (COA) containing Reverse-Phase HPLC chromatograms showing >98% purity and Mass Spectrometry (MS) confirming exact sequence molecular weight. PX1 Research provides batch-matched COAs for every shipment.
What is the difference between Follistatin-344 and Follistatin-315?
Follistatin-344 is a precursor protein that includes a 29-amino-acid signal peptide. Upon cellular cleavage, FS-344 becomes the circulating FS-315 isoform. In preclinical literature, both designations refer to the non-heparin-binding circulating variant of the peptide.
Why is endotoxin testing critical for research-grade Follistatin?
Bacterial endotoxins (LPS) can stimulate Toll-Like Receptor 4 (TLR4) on cell membranes, triggering uncontrolled inflammatory cascades. This induces cellular toxicity or skewed experimental results in cell culture and preclinical tissue models.
What solvent should be used to reconstitute lyophilized Follistatin?
Reconstitution is typically performed using sterile Phosphate-Buffered Saline (PBS, pH 7.4) or sterile Bacteriostatic Water for laboratory applications. The choice depends on target assay conditions and cell culture tolerance.
What is the physical storage stability of lyophilized Follistatin?
In its lyophilized state, follistatin remains stable for up to 24 months when stored at -20°C to -80°C in a manual-defrost freezer away from light exposure.
Can Follistatin be repeatedly frozen and thawed after reconstitution?
No. Repeated freeze-thaw cycles break disulfide bonds and cause mechanical degradation or aggregation of the protein structure. Reconstituted follistatin should be partitioned into single-use aliquots prior to freezing at -80°C.
Does PX1 Research supply Follistatin for clinical or medical use?
No. All compounds supplied by PX1 Research are synthesized strictly for laboratory in vitro and preclinical research use only. They are not intended for human or animal medical diagnostic, therapeutic, or clinical applications.
Where does PX1 Research ship original Follistatin from?
All orders are fulfilled directly from our specialized fulfillment facilities situated in California and Arizona, USA. Orders received before cut-off times Monday through Friday ship same-day.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.